CVS Caremark now covers Lilly's full obesity portfolio, giving all three major PBMs access to Zepbound and Foundayo and ...

David Ricks was addressing the pharmaceutical titan's latest hot product.

Select hospitals have refused to share data to prove they’re not double-dipping drug discounts, Lilly said. The drugmaker is ...

Eli Lilly (NYSE:LLY | LLY Price Prediction) is growing like a software company. Q1 2026 revenue hit $19.80B, up 55.5% year ...

The Big Pharma is paying up to $1.5 billion, split between an upfront fee and a milestone payment, to buy shingles vaccine ...

Eli Lilly is rated SELL due to lofty valuation, despite extraordinary execution and recent market leadership in GLP-1 and obesity drugs. LLY's current $950B market cap implies sustained 25% annual ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The Eli Lilly logo appears on a laptop computer screen in this photo illustration in Athens, ...